It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
SCCmec is a large mobile genetic element that includes the mecA gene and confers resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus (MRSA). There is evidence that SCCmec disseminates among staphylococci, but the transfer mechanisms are unclear. Here, we show that two-component systems mediate the upregulation of natural competence genes in S. aureus under biofilm growth conditions, and this enhances the efficiency of natural transformation. We observe SCCmec transfer via natural transformation from MRSA, and from methicillin-resistant coagulase-negative staphylococci, to methicillin-sensitive S. aureus. The process requires the SCCmec recombinase genes ccrAB, and the stability of the transferred SCCmec varies depending on SCCmec types and recipients. Our results suggest that natural transformation plays a role in the transfer of SCCmec and possibly other mobile genetic elements in S. aureus biofilms.
SCCmec is a large mobile genetic element that confers resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus. Here, the authors show that biofilm growth conditions enhance the efficiency of natural transformation in S. aureus and allow the transfer of SCCmec to methicillin-sensitive strains.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 University of Tsukuba, Graduate School of Comprehensive Human Sciences, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)
2 University of Tsukuba, Human Biology Program, School of Integrative and Global Majors, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); Biotechnology Centre of Ho Chi Minh City, District 12, HCM City, Vietnam (GRID:grid.20515.33)
3 Institut Pasteur, Université Paris Cité, CNRS UMR6047, Biology of Gram-Positive Pathogens, Department of Microbiology, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535); University of Tsukuba, Division of Biomedical Science, Faculty of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)
4 Inc., Kamiyokoba, Kotobiken Medical Laboratories, Tsukuba, Japan (GRID:grid.20515.33)
5 Institut Pasteur, Université Paris Cité, CNRS UMR6047, Biology of Gram-Positive Pathogens, Department of Microbiology, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)
6 University of Tsukuba, Division of Biomedical Science, Faculty of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)